Clinical trials
Psychotic Disorders trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 17 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shalvata Mental Health Center | 6 |
| Sheba Medical Center | 6 |
| Alkermes, Inc. | 2 |
| Beersheva Mental Health Center | 2 |
| Eli Lilly and Company | 2 |
| Herzog Hospital | 2 |
| Rene Kahn | 2 |
| Sha'ar Menashe Mental Health Center | 2 |
| University of Oxford | 2 |
| Abarbanel Mental Health Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 44 |
| Schizophrenia | 32 |
| Mood Disorders | 4 |
| Bipolar Disorder | 3 |
| Cognitive Dysfunction | 3 |
| Alzheimer Disease | 2 |
| Anxiety Disorders | 2 |
| Marijuana Abuse | 2 |
| Mental Disorders | 2 |
| Personality Disorders | 2 |
Trials
Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.